Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study
Vasiliki Mamakou(National and Kapodistrian University of Athens), Eleftheria Zeggini(TUM Klinikum), Bram P. Prins(Wellcome Sanger Institute), Karoline Kuchenbaecker(University of Cambridge), Nikolaοs Tentolouris, Eirini Glezou, George Dedoussis(Harokopio University of Athens), Eleni Zengini(KAT General Hospital of Attica), E Tsompanaki(Athens University of Economics and Business), Anastasia Thanopoulou(National and Kapodistrian University of Athens), Klea Lamnissou(National and Kapodistrian University of Athens), Ioannis Serafetinidis, Lorraine Southam(Essen University Hospital), Athina Karabela, Fragiskos Gonidakis(National and Kapodistrian University of Athens), Eirini Marouli(Queen Mary University of London), Sophie Hackinger(Wellcome Sanger Institute), V.P. Kontaxakis(National and Kapodistrian University of Athens), Nigel W. Rayner(Centre for Human Genetics)
Cited by 5
Related Papers
A reference panel of 64,976 haplotypes for genotype imputation
|Nature Genetics|2016|3.3k
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
|Nature Genetics|2018|1.5k
Genome-wide association study identifies eight loci associated with blood pressure
|Nature Genetics|2009|1.2k
Mapping the human genetic architecture of COVID-19
|Nature|2021|1.1k